Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 509 entries
Sorted by: Best Match Show Resources per page
Faciometer.

Panminerva medica

Farkas LG, Hajnis K.
PMID: 5792008
Panminerva Med. 1969 Apr;11(4):165-9.

No abstract available.

Cite
Farkas LG, Hajnis K. Faciometer. Panminerva Med. 1969;11(4):165-9
Farkas, L. G., & Hajnis, K. (1969). Faciometer. Panminerva medica, 11(4), 165-9.
Farkas, L G, and Hajnis, K. "Faciometer." Panminerva medica vol. 11,4 (1969): 165-9.
Farkas LG, Hajnis K. Faciometer. Panminerva Med. 1969 Apr;11(4):165-9. PMID: 5792008.
Copy Download .nbib Format: NLM
Which first-line treatment in Piedmont in the year 2017?.

Panminerva medica

Berrutti M, Leone N.
PMID: 28290187
Panminerva Med. 2017 Jun;59(2):197. doi: 10.23736/S0031-0808.16.03286-9.

No abstract available.

Cite
Berrutti M, Leone N. Which first-line treatment in Piedmont in the year 2017?. Panminerva Med. 2017;59(2):197doi: 10.23736/S0031-0808.16.03286-9.
Berrutti, M., & Leone, N. (2017). Which first-line treatment in Piedmont in the year 2017?. Panminerva medica, 59(2), 197. https://doi.org/10.23736/S0031-0808.16.03286-9
Berrutti, Mara, and Leone, Nicola. "Which first-line treatment in Piedmont in the year 2017?." Panminerva medica vol. 59,2 (2017): 197. doi: https://doi.org/10.23736/S0031-0808.16.03286-9
Berrutti M, Leone N. Which first-line treatment in Piedmont in the year 2017?. Panminerva Med. 2017 Jun;59(2):197. doi: 10.23736/S0031-0808.16.03286-9. PMID: 28290187.
Copy Download .nbib Format: NLM
Research on the correlation between MMP gene polymorphism and susceptibility to cervical cancer in Chinese women.

Panminerva medica

Chen L, Qiang P, Shao Y.
PMID: 28994565
Panminerva Med. 2017 Oct 09; doi: 10.23736/S0031-0808.17.03361-4. Epub 2017 Oct 09.

No abstract available.

Cite
Chen L, Qiang P, Shao Y. Research on the correlation between MMP gene polymorphism and susceptibility to cervical cancer in Chinese women. Panminerva Med. 2017;doi: 10.23736/S0031-0808.17.03361-4.
Chen, L., Qiang, P., & Shao, Y. (2017). Research on the correlation between MMP gene polymorphism and susceptibility to cervical cancer in Chinese women. Panminerva medica, . https://doi.org/10.23736/S0031-0808.17.03361-4
Chen, Lijuan, et al. "Research on the correlation between MMP gene polymorphism and susceptibility to cervical cancer in Chinese women." Panminerva medica vol. (2017). doi: https://doi.org/10.23736/S0031-0808.17.03361-4
Chen L, Qiang P, Shao Y. Research on the correlation between MMP gene polymorphism and susceptibility to cervical cancer in Chinese women. Panminerva Med. 2017 Oct 09; doi: 10.23736/S0031-0808.17.03361-4. Epub 2017 Oct 09. PMID: 28994565.
Copy Download .nbib Format: NLM
Growth of the immature child from birth to the age of four.

Panminerva medica

NICOLA P, ANSALDI N.
PMID: 13728813
Panminerva Med. 1961 Mar;3:109-17.

No abstract available.

Cite
NICOLA P, ANSALDI N. Growth of the immature child from birth to the age of four. Panminerva Med. 1961;3:109-17
NICOLA, P., & ANSALDI, N. (1961). Growth of the immature child from birth to the age of four. Panminerva medica, 3109-17.
NICOLA, P, and ANSALDI, N. "Growth of the immature child from birth to the age of four." Panminerva medica vol. 3 (1961): 109-17.
NICOLA P, ANSALDI N. Growth of the immature child from birth to the age of four. Panminerva Med. 1961 Mar;3:109-17. PMID: 13728813.
Copy Download .nbib Format: NLM
The historical significance of the St. Vincent Awards.

Panminerva medica

WAKSMAN SA.
PMID: 14004490
Panminerva Med. 1962 May;4:201-2.

No abstract available.

Cite
WAKSMAN SA. The historical significance of the St. Vincent Awards. Panminerva Med. 1962;4:201-2
WAKSMAN, S. A. (1962). The historical significance of the St. Vincent Awards. Panminerva medica, 4201-2.
WAKSMAN, S A. "The historical significance of the St. Vincent Awards." Panminerva medica vol. 4 (1962): 201-2.
WAKSMAN SA. The historical significance of the St. Vincent Awards. Panminerva Med. 1962 May;4:201-2. PMID: 14004490.
Copy Download .nbib Format: NLM
G. B. Piranesi (1720-1778) engraver, architect, archeologist.

Panminerva medica

ROCCHIETTA S.
PMID: 13974514
Panminerva Med. 1963 May;5:146-7.

No abstract available.

Cite
ROCCHIETTA S. G. B. Piranesi (1720-1778) engraver, architect, archeologist. Panminerva Med. 1963;5:146-7
ROCCHIETTA, S. (1963). G. B. Piranesi (1720-1778) engraver, architect, archeologist. Panminerva medica, 5146-7.
ROCCHIETTA, S. "G. B. Piranesi (1720-1778) engraver, architect, archeologist." Panminerva medica vol. 5 (1963): 146-7.
ROCCHIETTA S. G. B. Piranesi (1720-1778) engraver, architect, archeologist. Panminerva Med. 1963 May;5:146-7. PMID: 13974514.
Copy Download .nbib Format: NLM
Put my name on the paper: the Hollywood syndrome.

Panminerva medica

Dalainas I.
PMID: 17468734
Panminerva Med. 2007 Mar;49(1):43.

No abstract available.

Cite
Dalainas I. Put my name on the paper: the Hollywood syndrome. Panminerva Med. 2007;49(1):43
Dalainas, I. (2007). Put my name on the paper: the Hollywood syndrome. Panminerva medica, 49(1), 43.
Dalainas, I. "Put my name on the paper: the Hollywood syndrome." Panminerva medica vol. 49,1 (2007): 43.
Dalainas I. Put my name on the paper: the Hollywood syndrome. Panminerva Med. 2007 Mar;49(1):43. PMID: 17468734.
Copy Download .nbib Format: NLM
How to treat COPD: a critical appraisal of the FLAME Trial.

Panminerva medica

Cavalleri MA, Diaz De Teran T, Barlascini C, Banfi P, Nicolini A.
PMID: 30727710
Panminerva Med. 2019 Feb 06; doi: 10.23736/S0031-0808.19.03569-9. Epub 2019 Feb 06.

No abstract available.

Cite
Cavalleri MA, Diaz De Teran T, Barlascini C, et al. How to treat COPD: a critical appraisal of the FLAME Trial. Panminerva Med. 2019;doi: 10.23736/S0031-0808.19.03569-9.
Cavalleri, M. A., Diaz De Teran, T., Barlascini, C., Banfi, P., & Nicolini, A. (2019). How to treat COPD: a critical appraisal of the FLAME Trial. Panminerva medica, . https://doi.org/10.23736/S0031-0808.19.03569-9
Cavalleri, Maurizio A, et al. "How to treat COPD: a critical appraisal of the FLAME Trial." Panminerva medica vol. (2019). doi: https://doi.org/10.23736/S0031-0808.19.03569-9
Cavalleri MA, Diaz De Teran T, Barlascini C, Banfi P, Nicolini A. How to treat COPD: a critical appraisal of the FLAME Trial. Panminerva Med. 2019 Feb 06; doi: 10.23736/S0031-0808.19.03569-9. Epub 2019 Feb 06. PMID: 30727710.
Copy Download .nbib Format: NLM
Troxerutin attenuates isoproterenol-induced cardiac hypertrophy via the LKB1/AMPK/mTOR pathway.

Panminerva medica

Zhao J, Chen D, Feng C.
PMID: 31352760
Panminerva Med. 2021 Jun;63(2):233-234. doi: 10.23736/S0031-0808.19.03676-0. Epub 2019 Jul 25.

No abstract available.

Cite
Zhao J, Chen D, Feng C. Troxerutin attenuates isoproterenol-induced cardiac hypertrophy via the LKB1/AMPK/mTOR pathway. Panminerva Med. 2019;63(2):233-234doi: 10.23736/S0031-0808.19.03676-0.
Zhao, J., Chen, D., & Feng, C. (2021). Troxerutin attenuates isoproterenol-induced cardiac hypertrophy via the LKB1/AMPK/mTOR pathway. Panminerva medica, 63(2), 233-234. https://doi.org/10.23736/S0031-0808.19.03676-0
Zhao, Junfa, et al. "Troxerutin attenuates isoproterenol-induced cardiac hypertrophy via the LKB1/AMPK/mTOR pathway." Panminerva medica vol. 63,2 (2021): 233-234. doi: https://doi.org/10.23736/S0031-0808.19.03676-0
Zhao J, Chen D, Feng C. Troxerutin attenuates isoproterenol-induced cardiac hypertrophy via the LKB1/AMPK/mTOR pathway. Panminerva Med. 2021 Jun;63(2):233-234. doi: 10.23736/S0031-0808.19.03676-0. Epub 2019 Jul 25. PMID: 31352760.
Copy Download .nbib Format: NLM
Effects of MiR-34a on the proliferation and apoptosis of osteoarthritis chondrocytes via the ERK1/2 pathway.

Panminerva medica

Yu Z, Zhang H, Jia G, Hu P, Huang J, Cong Z, Yu X.
PMID: 31355598
Panminerva Med. 2021 Jun;63(2):241-242. doi: 10.23736/S0031-0808.19.03688-7. Epub 2019 Jul 26.

No abstract available.

Cite
Yu Z, Zhang H, Jia G, et al. Effects of MiR-34a on the proliferation and apoptosis of osteoarthritis chondrocytes via the ERK1/2 pathway. Panminerva Med. 2019;63(2):241-242doi: 10.23736/S0031-0808.19.03688-7.
Yu, Z., Zhang, H., Jia, G., Hu, P., Huang, J., Cong, Z., & Yu, X. (2021). Effects of MiR-34a on the proliferation and apoptosis of osteoarthritis chondrocytes via the ERK1/2 pathway. Panminerva medica, 63(2), 241-242. https://doi.org/10.23736/S0031-0808.19.03688-7
Yu, Zhiping, et al. "Effects of MiR-34a on the proliferation and apoptosis of osteoarthritis chondrocytes via the ERK1/2 pathway." Panminerva medica vol. 63,2 (2021): 241-242. doi: https://doi.org/10.23736/S0031-0808.19.03688-7
Yu Z, Zhang H, Jia G, Hu P, Huang J, Cong Z, Yu X. Effects of MiR-34a on the proliferation and apoptosis of osteoarthritis chondrocytes via the ERK1/2 pathway. Panminerva Med. 2021 Jun;63(2):241-242. doi: 10.23736/S0031-0808.19.03688-7. Epub 2019 Jul 26. PMID: 31355598.
Copy Download .nbib Format: NLM
miR-424-5p inhibited malignant behavior of colorectal cancer cells by targeting CCNE1.

Panminerva medica

Jiang B, Wu D, Huang L, Fang H.
PMID: 31355613
Panminerva Med. 2019 Jul 29; doi: 10.23736/S0031-0808.19.03708-X. Epub 2019 Jul 29.

No abstract available.

Cite
Jiang B, Wu D, Huang L, et al. miR-424-5p inhibited malignant behavior of colorectal cancer cells by targeting CCNE1. Panminerva Med. 2019;doi: 10.23736/S0031-0808.19.03708-X.
Jiang, B., Wu, D., Huang, L., & Fang, H. (2019). miR-424-5p inhibited malignant behavior of colorectal cancer cells by targeting CCNE1. Panminerva medica, . https://doi.org/10.23736/S0031-0808.19.03708-X
Jiang, Binhua, et al. "miR-424-5p inhibited malignant behavior of colorectal cancer cells by targeting CCNE1." Panminerva medica vol. (2019). doi: https://doi.org/10.23736/S0031-0808.19.03708-X
Jiang B, Wu D, Huang L, Fang H. miR-424-5p inhibited malignant behavior of colorectal cancer cells by targeting CCNE1. Panminerva Med. 2019 Jul 29; doi: 10.23736/S0031-0808.19.03708-X. Epub 2019 Jul 29. PMID: 31355613.
Copy Download .nbib Format: NLM
CT characteristics and prognosis of peripheral lung cancer.

Panminerva medica

Wang L, Che H.
PMID: 31577089
Panminerva Med. 2019 Sep 24; doi: 10.23736/S0031-0808.19.03743-1. Epub 2019 Sep 24.

No abstract available.

Cite
Wang L, Che H. CT characteristics and prognosis of peripheral lung cancer. Panminerva Med. 2019;doi: 10.23736/S0031-0808.19.03743-1.
Wang, L., & Che, H. (2019). CT characteristics and prognosis of peripheral lung cancer. Panminerva medica, . https://doi.org/10.23736/S0031-0808.19.03743-1
Wang, Longjiang, and Che, Hong. "CT characteristics and prognosis of peripheral lung cancer." Panminerva medica vol. (2019). doi: https://doi.org/10.23736/S0031-0808.19.03743-1
Wang L, Che H. CT characteristics and prognosis of peripheral lung cancer. Panminerva Med. 2019 Sep 24; doi: 10.23736/S0031-0808.19.03743-1. Epub 2019 Sep 24. PMID: 31577089.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 509 entries